Damaged small intestine repaired with hPSC-derived organoids
Cincinnati Children’s have repaired damaged intestines in a rodent model, moving research efforts closer to clinical trials.
List view / Grid view
Cincinnati Children’s have repaired damaged intestines in a rodent model, moving research efforts closer to clinical trials.
Understanding the signalling pathway controlling neural stem cell reactivation could offer a strategy for using existing drugs to treat neurodevelopmental disorders.
Organoids with SMA-pathology uncovered key findings about the disease, which could be utilised to develop new therapeutic options.
31 July 2024 | By bit.bio
Watch this webinar to discover the latest astrocyte research and its implications for CNS drug discovery.
The agreement between Cartherics, The University of Sydney and The University of Queensland will further stem cell-derived heart muscle therapy for heart failure.
Mini-colons, which closely resemble in vivo tissue, were used for several applications, including the characterisation of anticancer drug toxicity profiles.
In this episode, we discuss how new insights into stem cell biology are leading to novel therapeutics in regenerative medicine beyond cell therapy.
We had the privilege of interviewing Brian Culley, CEO of Lineage Cell Therapeutics. He discusses how Lineage’s pluripotent stem cell platform is extraordinarily advantageous, details two early-stage programmes addressing auditory and vision disorders and reveals how Lineage is choosing to target conditions that will make a real difference.
The world’s first generation of human BBB organoids from hPSCs accurately replicated features of cerebral cavernous malformation.
Culture conditions during embryoid body formation can be enhanced to gain glia-associated proteins and neural network activity.
Researchers uncover a genetic pathway of parietal cell development, which will enable a better understanding of stomach conditions.
The new study provides proof of principle that functional liver cells can be grown in a different species, offering a potential solution to transplant shortage.
Researchers found that genetic depletion of cyclophilin A results in stem cells distinctively lacking intrinsically disordered proteins.
Induced NPCs facilitate the creation of patient-specific organoid models and improve identification of nephron targeted drugs.
A synthetic antibody selectively activates the Wnt signalling pathway and directs stem cells to differentiate into neurons.